TerminatedPhase 3NCT03265132
A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)
Studying Adult-onset Still disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Swedish Orphan Biovitrum
- Principal Investigator
- Sven Ohlman, MD PhD, LCSWSwedish Orphan Biovitrum
- Intervention
- anakinra(biological)
- Enrollment
- 13 enrolled
- Eligibility
- All sexes
- Timeline
- 2017 – 2019
Study locations (30)
- University of Alabama Birmingham, Birmingham, Alabama, United States
- Attune Health, Beverly Hills, California, United States
- Rady Children's Hospital & Health Center, San Diego, California, United States
- The Children's Hospital Colorado, Aurora, Colorado, United States
- University of Florida, Gainesville, Florida, United States
- University of Miami, Miami, Florida, United States
- Nicklaus Children's Hospital, Miami, Florida, United States
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
- Children's Mercy Hospital and Clinics, Kansas City, Kansas, United States
- University of Louisville School of Medicine Research Foundation, Louisville, Kentucky, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Saint Paul Rheumatology, Eagan, Minnesota, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03265132 on ClinicalTrials.govOther trials for Adult-onset Still disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07203001A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's DiseaseNovartis Pharmaceuticals
- ACTIVE NOT RECRUITINGPHASE3NCT05814159A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)Swedish Orphan Biovitrum
- RECRUITINGNCT04402086Rheumatology Patient Registry and BiorepositoryYale University
- RECRUITINGNCT03510442Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related ConditionsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- RECRUITINGNCT05927454Acostill ( RaDiCo Cohort) (RaDiCo Acostill)Institut National de la Santé Et de la Recherche Médicale, France
- RECRUITINGNCT02143986Glycosylated Ferritin in Macrophagic Activation SyndromesBrugmann University Hospital